Difference between revisions of "Team:ETH Zurich/Chip"

Line 4: Line 4:
 
<div class="expContainer">
 
<div class="expContainer">
 
<h1>Chip Design</h1>
 
<h1>Chip Design</h1>
−
<h2>Introduction</h2>
+
<h2>Our Different designs</h2>
 +
<h3>Introduction and first idea</h3>
 
<div class="imgBox" Right: style="float:right;width:65%;margin: 0px 0px 20px 20px !important;">
 
<div class="imgBox" Right: style="float:right;width:65%;margin: 0px 0px 20px 20px !important;">
 
<a href="https://2015.igem.org/File:MicrofluidicVeryFirstIdea.svg">
 
<a href="https://2015.igem.org/File:MicrofluidicVeryFirstIdea.svg">
Line 20: Line 21:
 
<p>One of the biggest challenges of circulating tumor cells is their scarcity in the blood of patients. To overcome this problem, our first idea was to develop a microfluidic chip in order to perform single cell analysis. The biggest advantage of using a microfluidic chip is its ability to perform high-throughput cell biology.  
 
<p>One of the biggest challenges of circulating tumor cells is their scarcity in the blood of patients. To overcome this problem, our first idea was to develop a microfluidic chip in order to perform single cell analysis. The biggest advantage of using a microfluidic chip is its ability to perform high-throughput cell biology.  
 
In order to do so, we wanted to produce water-in-oil emulsion droplets, that can then be sorted by a machine analogous to FACS, (inspired from [<a href="https://2015.igem.org/Team:ETH_Zurich/References#Chiu2015">Chiu 2015</a>]).  In the droplets, a mixture of bacteria and mammalian cells would be present. And the bacteria would express the green fluorescent protein only in the presence of cancer cells, exhibiting both increased lactate production rate and sensitivity to sTRAIL.  </p>
 
In order to do so, we wanted to produce water-in-oil emulsion droplets, that can then be sorted by a machine analogous to FACS, (inspired from [<a href="https://2015.igem.org/Team:ETH_Zurich/References#Chiu2015">Chiu 2015</a>]).  In the droplets, a mixture of bacteria and mammalian cells would be present. And the bacteria would express the green fluorescent protein only in the presence of cancer cells, exhibiting both increased lactate production rate and sensitivity to sTRAIL.  </p>
−
<h2>First Design</h2>
+
<h3>First Design</h3>
 +
<div class="imgBox" Right: style="float:right;width:65%;margin: 0px 0px 20px 20px !important;">
 +
<a href="https://2015.igem.org/File:MicrofluidicFormerDesign.svg">
 +
<!--[if gte IE 9]><!-->
 +
<object class="svg" id="MicrofluidicVeryFirstIdea " data="https://static.igem.org/mediawiki/2015/1/1d/MicrofluidicFormerDesign.svg" type="image/svg+xml" width="WIDTH" height="HEIGHT" style="overflow:hidden">
 +
<img src="IMG FALLBACK URL" />
 +
</object>
 +
<!--<![endif]-->
 +
<!--[if lte IE 8]>
 +
<img src="IMG FALLBACK URL" />
 +
<![endif]-->
 +
</a>
 +
<p>First design of the microfluidic chip</p>
 +
</div>
 
<p> However due to the complexity of this setup, we decided to first explore another design consisting of valves and chambers. Instead of having droplets to isolate single cells, we wanted to have a two-layer microfluidic chip. One of the layer would have been the flow of cells and the other layer, valves controlled by pressure that are able to close the chambers. </p>
 
<p> However due to the complexity of this setup, we decided to first explore another design consisting of valves and chambers. Instead of having droplets to isolate single cells, we wanted to have a two-layer microfluidic chip. One of the layer would have been the flow of cells and the other layer, valves controlled by pressure that are able to close the chambers. </p>
−
<h2>Realistic Design</h2>
+
<h3>Realistic and Final Design</h3>
 +
<div class="imgBox" Right: style="float:right;width:65%;margin: 0px 0px 20px 20px !important;">
 +
<a href="https://2015.igem.org/File:MicrofluidicNewDesign.svg">
 +
<!--[if gte IE 9]><!-->
 +
<object class="svg" id="MicrofluidicNewDesign " data="https://static.igem.org/mediawiki/2015/d/df/MicrofluidicNewDesign.svg" type="image/svg+xml" width="WIDTH" height="HEIGHT" style="overflow:hidden">
 +
<img src="IMG FALLBACK URL" />
 +
</object>
 +
<!--<![endif]-->
 +
<!--[if lte IE 8]>
 +
<img src="IMG FALLBACK URL" />
 +
<![endif]-->
 +
</a>
 +
<p>Final design of the microfluidic chip</p>
 +
</div>
 
</div>
 
</div>
  
 
</div>
 
</div>
 
</html>
 
</html>

Revision as of 09:14, 5 September 2015

"What I cannot create I do not understand."
- Richard Feynmann

Chip Design

Our Different designs

Introduction and first idea

Idea design of microfluidic chip

One of the biggest challenges of circulating tumor cells is their scarcity in the blood of patients. To overcome this problem, our first idea was to develop a microfluidic chip in order to perform single cell analysis. The biggest advantage of using a microfluidic chip is its ability to perform high-throughput cell biology. In order to do so, we wanted to produce water-in-oil emulsion droplets, that can then be sorted by a machine analogous to FACS, (inspired from [Chiu 2015]). In the droplets, a mixture of bacteria and mammalian cells would be present. And the bacteria would express the green fluorescent protein only in the presence of cancer cells, exhibiting both increased lactate production rate and sensitivity to sTRAIL.

First Design

First design of the microfluidic chip

However due to the complexity of this setup, we decided to first explore another design consisting of valves and chambers. Instead of having droplets to isolate single cells, we wanted to have a two-layer microfluidic chip. One of the layer would have been the flow of cells and the other layer, valves controlled by pressure that are able to close the chambers.

Realistic and Final Design

Final design of the microfluidic chip